论文部分内容阅读
2015年6月25日,由中国卫计委肺癌质控中心、中国卫计委临床病理质控中心、中国临床肿瘤协会及中国胸部肿瘤研究协作组四家机构联合发起,阿斯利康(中国)协办的“精准医学规范前行—肺癌规范化诊疗万里行”项目在广州正式启动。吴一龙教授作为此次项目的发起人表示:“近些年,肿瘤分子诊断的发展及靶向药物的广泛应
On June 25, 2015, AstraZeneca (China) Co., Ltd. jointly sponsored by the four organizations of the Chinese Academy of Medical Sciences’s Lung Cancer Control Center, China’s State Health and Welfare Commission’s Clinical Pathology and Quality Control Center, China Society of Clinical Oncology and China Thoracic Oncology Research Collaboration. Co-sponsored ”Precise Medical Standards - lung standardized treatment Miles“ project was officially launched in Guangzhou. As a sponsor of the project, Professor Wu Yilong said: ”In recent years, the development of molecular diagnosis of tumors and the wide range of targeted drugs